Peptide Therapeutics Market Future Scope : Unraveling the Potential of Precision Medicine and Forecast 2023-2030 | Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG

Market Overview:

Peptide therapeutics are small protein fragments that interact with receptors, enzymes, and other proteins. They are used for modulation of physiological processes. Some key applications of peptide therapeutics include metabolic disorders, cancer, cardiovascular disorders, central nervous system diseases, infectious diseases, and other indications.

Market Dynamics:

The growth of the peptide therapeutics market is driven by factors such as increased research and development activities by pharmaceutical companies and rising prevalence of metabolic disorders and cancer. Peptide therapeutics offer advantages over conventional small-molecule drugs such as high selectivity and low toxicity. Various peptide-based drugs and pipeline candidates are under development by companies for indications such as prostate cancer, acromegaly, Cushing's disease, and others. Additionally, technological advancements in designing and production of peptide therapeutics have enabled development of highly potent molecules, thus propelling the market growth.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/1837

Market Drivers for the Peptide Therapeutics Market

Increased R&D Investments and Growing Focus on Peptide Therapeutics Development

The peptide therapeutics market has witnessed significant increase in research and development investments by various biopharmaceutical companies and research organizations over the past decade. This is due to the growing recognition of peptides as an important class of drug molecules with high potency, high selectivity, and low toxicity. Peptide-based drugs can be used for treatment of various diseases such as cancer, metabolic disorders, cardiovascular diseases, and infectious diseases. Leading companies are engaged in development of novel peptide-based drug candidates for a wide range of clinical applications. For instance, Amgen invested over $6 billion in R&D in 2020, a portion of which was allocated for development of new peptide drugs and therapeutics. Such increased focus on peptide drug research is a major factor supporting the growth of the peptide therapeutics market.

Growing Prevalence of Chronic Diseases Requiring Medication

The global burden of chronic diseases has been on the rise over the past few decades. Diseases such as cancer, diabetes, cardiovascular diseases have affected millions of lives worldwide. As per WHO, chronic diseases accounted for approximately 60% of all deaths globally in 2001. This number is expected to further increase in the coming years. The treatment of chronic diseases often requires long-term medication. Peptide-based drugs have emerged as an important therapeutic option due to their high target selectivity and fewer side effects compared to traditional drugs. Therefore, the growing prevalence of chronic diseases globally has boosted the demand for efficacious and safe peptide therapeutics, thus driving the market growth.

Market Restrain for the Peptide Therapeutics Market

High Development Cost Associated with Peptide Drug Production

While the immense potential of peptides as drugs is well established, their development and production faces certain challenges that restricts widespread adoption. Peptide therapeutics require complex manufacturing processes which makes their production quite expensive. The multi-step synthesis and purification processes involved in producing therapeutic-grade peptides contributes significantly to high capital and operational costs. Compared to traditional drugs, peptides have low manufacturing yields and more extensive validation requirements which further inflates costs. The expensive production process poses a major obstacle especially for startup biotechs developing novel peptide candidates. High costs compromise the commercial viability of some promising peptide drugs. This acts as a major restrain for the peptide therapeutics market.

Key Market Opportunity for the Peptide Therapeutics Market

Increased Focus on Personalized Medicine

Personalized medicine involves tailoring medical treatment to individual characteristics, needs, and predicted response to specific therapies. With advancements in fields such as pharmacogenomics and precision medicine, there is growing focus on developing personalized treatment regimens. Peptides are well suited for personalized medicine due to their high selectivity. Short therapeutic peptides can be custom-designed for targeting specific pathways of individual patients. Compared to conventional drugs, peptides provide targeted interactions. Leading pharmaceutical companies are investing in personalized peptide therapeutics. For instance, Roche is developing a personalized cancer vaccine approach based on patient-specific neoantigens. The growing shift towards personalized healthcare presents a major opportunity for growth of the peptide therapeutics market. Nanoparticle-based drug delivery of peptides also facilitates targeted delivery critical for personalized therapies.

Emerging Trend in the Peptide Therapeutics Market

Increasing Adoption of Nanotechnology for Delivery of Peptide Drugs

One of the key trends in the peptide therapeutics market is the increasing adoption of nanotechnology-based drug delivery approaches. Encapsulation of peptide drugs within nanoparticles offers advantages such as controlled drug release, stability, targeting, and biocompatibility. Various nanocarrier systems under investigation for peptide delivery include liposomes, polymeric nanoparticles, micelles, dendrimers, viral nanoparticles and exosomes. For example, FOLOTYN (pegylated liposomal formulation of chemotherapy drug) obtained FDA approval for delivery of peptide drug angiopep-2 across BBB. Peptide conjugation with nanoparticles also helps address issues pertaining to short half-life and enzymatic degradation. This emerging area of 'nanonization' has potential to overcome several challenges associated with peptide drug delivery.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/1837

List of TOP Players in Market Report are: -

◘ Teva Pharmaceutical Industries Ltd
◘ Novo Nordisk A/S
◘ OPKO Health Inc.
◘ Lilly
◘ Hanmi Pharm.Co.
◘ Sanofi
◘ Circle Pharma
◘ Pfizer Inc.
◘ Novartis AG
◘ PeptiDream Inc.
◘ Amgen Inc.
◘ AstraZeneca
◘ Bachem Holding AG
◘ CordenPharma International
◘ Ipsen Pharma
◘ Merck KGaA
◘ PolyPeptide Group
◘ Bayer AG.

Note: Major Players are sorted in no particular order.

Market Detailed Segmentation:

By Product Type:

Branded Peptide
Generic Peptide

By Application:

Cancer
Cardiovascular diseases
Metabolic diseases
Respiratory diseases
Infectious diseases
Others

By Route of Administration:

Oral Administration
Parenteral Administration
Others

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2021
The base year for estimation - is 2021
Estimated Year - 2023
Forecast period** - 2023 to 2030

This Peptide Therapeutics Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Peptide Therapeutics market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Peptide Therapeutics market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Peptide Therapeutics Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Peptide Therapeutics , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Peptide Therapeutics in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Peptide Therapeutics Market?

Summarized Extracts from TOC of Market Study

Chapter 1 Peptide Therapeutics Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Peptide Therapeutics

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Peptide Therapeutics industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Peptide Therapeutics Market Analysis by Countries

Chapter 9 Asia Pacific Peptide Therapeutics Market Analysis by Countries

Chapter 10 Middle East and Africa Peptide Therapeutics Market Analysis by Countries

Chapter 11 South America Peptide Therapeutics Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.